Page 28 | Certara

eBook

Medical Writing Special Edition: The Force Behind the Speed – Medical Writing’s Role in Regulatory Submissions

The cost of developing a single drug exceeds $2.6 billion, and the demand for life-saving…

CertaraMarch 24, 2025

Webinar

Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar]

CertaraMarch 21, 2025

Blog

Protect Confidential Information in Investigational Drug Submissions

March 20, 2025 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information…

CertaraMarch 20, 2025

Publication

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety,…

CertaraMarch 20, 2025

Announcement

Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan

RADNOR, PA – March 18, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraMarch 19, 2025

On-Demand Webinar

Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research

In this on demand webinar, you’ll discover why Phoenix Hosted is the ideal solution for…

CertaraMarch 19, 2025

Blog

FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format

March 19, 2025 The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the…

CertaraMarch 19, 2025

Announcement

Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities

March 17, 2025 Radnor, PA – – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraMarch 17, 2025

Brochure

Libra product overview

Discover Libra, the innovative tool that transforms DILI prediction in early drug discovery. By optimizing…

CertaraMarch 14, 2025

Press Coverage

How biosimulation and virtual trials can bust through clinical trial roadblocks

Discover how using biosimulation for rare disease drug development can help overcome statistical and recruitment…

CertaraMarch 14, 2025

Medical Writing Special Edition: The Force Behind the Speed – Medical Writing’s Role in Regulatory Submissions

Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar]

Protect Confidential Information in Investigational Drug Submissions

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan

Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research

FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format

Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities

Libra product overview

How biosimulation and virtual trials can bust through clinical trial roadblocks

Newsletter sign up

Quick links

Solutions

Contact